UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 160

Sortiert nach

Tofacitinib for Psoriatic Arthritis in Patients with an Inadequate Response to TNF Inhibitors

The New England journal of medicine, 2017-10, Vol.377 (16), p.1525-1536

2017

Volltextzugriff (PDF)

Biosimilars

2022

Volltextzugriff (PDF)

Benzbromarone in the treatment of gout

Advances in rheumatology (London, England), 2019-08, Vol.59 (1), p.37-37, Article 37

2019

Volltextzugriff (PDF)

Lessons Learned from the COVID-19 Pandemic: Interpreting Vaccination Strategies in a Nationwide Demographic Study

Vaccines (Basel), 2024-06, Vol.12 (6), p.581

2024

Volltextzugriff (PDF)

Prevention and management of herpes zoster in patients with rheumatoid arthritis and psoriatic arthritis: a clinical review

Clinical and experimental rheumatology, 2022-01, Vol.40 (1), p.162

2022

Volltextzugriff (PDF)

TNF-α–induced protein 3 (TNFAIP3)/A20 acts as a master switch in TNF-α blockade–driven IL-17A expression

Journal of allergy and clinical immunology, 2018-08, Vol.142 (2), p.517-529

2018

Volltextzugriff (PDF)

The landscape of systemic lupus erythematosus in Brazil: An expert panel review and recommendations

Lupus, 2021-09, Vol.30 (10), p.1684-1695

2021

Volltextzugriff (PDF)

Endpoints for extraintestinal manifestations in inflammatory bowel disease trials: the EXTRA consensus from the International Organization for the Study of Inflammatory Bowel Diseases

The lancet. Gastroenterology & hepatology, 2022-03, Vol.7 (3), p.254-261

2022

Volltextzugriff (PDF)

Prevalence, demographics, and clinical characteristics of Latin American patients with spondyloarthritis

Advances in rheumatology (London, England), 2021-01, Vol.61 (1), p.2-2, Article 2

2021

Volltextzugriff (PDF)

Biopharmaceuticals for rheumatic diseases in Latin America, Europe, Russia, and India: Innovators, biosimilars, and intended copies

Joint, bone, spine : revue du rhumatisme, 2014-12, Vol.81 (6), p.471-477

2014

Volltextzugriff (PDF)

Allopurinol, Benzbromarone, or a Combination in Treating Patients with Gout: Analysis of a Series of Outpatients

International Journal of Rheumatology, 2014-01, Vol.2014 (2014), p.263720-5

2014

Volltextzugriff (PDF)

Gender Differences in Perceptions of Psoriatic Arthritis Disease Impact, Management, and Physician Interactions: Results from a Global Patient Survey

Rheumatology and therapy., 2024-07

2024

Volltextzugriff (PDF)

Biosimilars in rheumatology: perspective and concerns

Rheumatology (Oxford, England), 2014-03, Vol.53 (3), p.389-390

2014

Volltextzugriff (PDF)

Practical Guidance on Biosimilars, With a Focus on Latin America: What Do Rheumatologists Need to Know?

Journal of clinical rheumatology, 2019-03, Vol.25 (2), p.91

2019

Volltextzugriff (PDF)

Home storage of biological medications administered to patients with rheumatic diseases

Advances in rheumatology (London, England), 2020-05, Vol.60 (1), p.30-30, Article 30

2020

Volltextzugriff (PDF)

Apoptosis and the FLIP and NF-kappa B proteins as pharmacodynamic criteria for biosimilar TNF-alpha antagonists

Biologics, 2014-01, Vol.8 (default), p.211-220

2014

Volltextzugriff (PDF)

Report on the Second PANLAR Review Course in Rheumatology: Biosimilars Update

Journal of clinical rheumatology, 2020-01, Vol.26 (1), p.33

2020

Volltextzugriff (PDF)

The future landscape of biosimilars in rheumatology: Where we are where we are going

Autoimmunity reviews, 2019-02, Vol.18 (2), p.203-208

2019

Volltextzugriff (PDF)

Partnership for productive development of biosimilar products: perspectives of access to biological products in the Brazilian market

Einstein (São Paulo, Brazil), 2018-09, Vol.16 (3), p.eRW4175-eRW4175

2018

Volltextzugriff (PDF)

Potential Regulatory and Commercial Environment for Biosimilars in Latin America

Value in health regional issues, 2012-12, Vol.1 (2), p.228-234

2012

Volltextzugriff (PDF)

Proceedings of the GRAPPA 2016 Retreat

Journal of rheumatology, 2017-05, Vol.44 (5), p.668

2017

Volltextzugriff (PDF)

Clear naming, traceability of biological medicines will protect patients

GaBI Journal, 2017-12, Vol.6 (4), p.153-154

2017

Volltextzugriff (PDF)

Median time to pain improvement and the impact of baseline pain severity on pain response in patients with psoriatic arthritis treated with tofacitinib

Rheumatic & musculoskeletal diseases open, 2021-07, Vol.7 (2), p.e001609

2021

Volltextzugriff (PDF)

New monoclonal antibody biosimilars approved in 2015 in Latin America: position statement of the Latin American Forum on Biosimilars on biosimilarity, interchangeability and extrapolation of indications

GaBI Journal, 2016-06, Vol.5 (2), p.66-69

2016

Volltextzugriff (PDF)

Risk factors and predictors of psoriatic arthritis in patients with psoriasis

Anais brasileiros de dermatología, 2013-03, Vol.88 (2), p.233-236

2013

Volltextzugriff (PDF)

1 – 25 von 160

Suche als RSS-Feed

Aktive Filter

ThemaMedicine

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(67)
Mit Volltextzugriff
(114)

Publikationsform

Artikel
(159)
Bücher
(1)

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Tofacitinib for Psoriatic Arthritis in Patients with an Inadequate Response to TNF Inhibitors

Biosimilars

Benzbromarone in the treatment of gout

Lessons Learned from the COVID-19 Pandemic: Interpreting Vaccination Strategies in a Nationwide Demographic Study

Prevention and management of herpes zoster in patients with rheumatoid arthritis and psoriatic arthritis: a clinical review

TNF-α–induced protein 3 (TNFAIP3)/A20 acts as a master switch in TNF-α blockade–driven IL-17A expression

The landscape of systemic lupus erythematosus in Brazil: An expert panel review and recommendations

Endpoints for extraintestinal manifestations in inflammatory bowel disease trials: the EXTRA consensus from the International Organization for the Study of Inflammatory Bowel Diseases

Prevalence, demographics, and clinical characteristics of Latin American patients with spondyloarthritis

Biopharmaceuticals for rheumatic diseases in Latin America, Europe, Russia, and India: Innovators, biosimilars, and intended copies

Allopurinol, Benzbromarone, or a Combination in Treating Patients with Gout: Analysis of a Series of Outpatients

Gender Differences in Perceptions of Psoriatic Arthritis Disease Impact, Management, and Physician Interactions: Results from a Global Patient Survey

Biosimilars in rheumatology: perspective and concerns

Practical Guidance on Biosimilars, With a Focus on Latin America: What Do Rheumatologists Need to Know?

Home storage of biological medications administered to patients with rheumatic diseases

Apoptosis and the FLIP and NF-kappa B proteins as pharmacodynamic criteria for biosimilar TNF-alpha antagonists

Report on the Second PANLAR Review Course in Rheumatology: Biosimilars Update

The future landscape of biosimilars in rheumatology: Where we are where we are going

Partnership for productive development of biosimilar products: perspectives of access to biological products in the Brazilian market

Potential Regulatory and Commercial Environment for Biosimilars in Latin America

Proceedings of the GRAPPA 2016 Retreat

Clear naming, traceability of biological medicines will protect patients

Median time to pain improvement and the impact of baseline pain severity on pain response in patients with psoriatic arthritis treated with tofacitinib

New monoclonal antibody biosimilars approved in 2015 in Latin America: position statement of the Latin American Forum on Biosimilars on biosimilarity, interchangeability and extrapolation of indications

Risk factors and predictors of psoriatic arthritis in patients with psoriasis

Aktive Filter

Suchergebnisse filtern